American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate‐Related Osteonecrosis of the Jaw – 2009 Update

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma

Fred Saad, Donald M. Gleason, Robin Murray et al. · JNCI Journal of the National Cancer Institute · 2002 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

Robert E. Marx, Yoh Sawatari, Michel Fortin et al. · Journal of Oral and Maxillofacial Surgery · 2005 · 1.6K citations

Medicine, Oral Pathology, Oral Surgery +12

Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

Henry G. Bone, David Hosking, Jean‐Pierre Devogelaer et al. · New England Journal of Medicine · 2004 · 1.4K citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +13

Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

F. Saad, D. M. Gleason, R. Murray et al. · JNCI Journal of the National Cancer Institute · 2004 · 1.2K citations

Medicine, Pharmacology, Pharmacotherapy +14